| 1-(3-(difluoromethyl)isothiazol-5-yl)-3-(2-fluoro-5-(hydroxymethyl)pyridin-4-yl)urea |
1-(3-(DIFLUOROMETHYL)ISOTHIAZOL-5-YL)-3-(2-FLUORO-5-(HYDROXYMETHYL)PYRIDIN-4-YL)UREA |
2270879-17-7 |
| 4-acetylphenyloxooxazolidinylmethylacetamide |
4-acetylphenyloxooxazolidinylmethylacetamide |
104421-21-8 |
| 2230186-18-0 |
VB-124 |
2230186-18-0 |
| 1-(sec-butyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole |
1-(仲丁基)-3-(4,4,5,5-四甲基-1,3,2-二氧杂硼戊烷-2-基)-1H-吡唑 |
2222997-43-3 |
| 4,6-Quinazolinediamine, N4-[4-(dimethylamino)phenyl]-5,6,7,8-tetrahydro-2-(4-pyridinyl)- |
4,6-Quinazolinediamine, N4-[4-(dimethylamino)phenyl]-5,6,7,8-tetrahydro-2-(4-pyridinyl)- |
2230854-93-8 |
| [1]Benzothieno[2,3-b]pyridine-3-carboxamide, N-[4-(aminosulfonyl)phenyl]-1,2,5,6,7,8-hexahydro-4-hydroxy-2-oxo- |
化合物 M435-1279 |
1359431-16-5 |
| (5S)-5-(aminomethyl)-3-(4-iodophenyl)-1,3-oxazolidin-2-one |
(5S)-5-(aminomethyl)-3-(4-iodophenyl)-1,3-oxazolidin-2-one |
501939-72-6 |
| 1-(5-(7-(3-morpholinopropoxy)quinazolin-4-ylthio)-1,3,4-thiadiazol-2-yl)-3-p-tolylurea |
FLT3-IN-1 |
1370256-78-2 |
| GSK2110183B |
1047645-82-8 |
1047645-82-8 |
| CID5721353 |
301356-95-6 |
301356-95-6 |
| 2135331-92-7 |
2135331-92-7 |
2135331-92-7 |
| Acetamide, 2-chloro-N-(2-cyanoethyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)- |
EN 106 |
757192-67-9 |
| 2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1) |
阿美替尼甲磺酸盐 |
2134096-06-1 |
| ALK/IGF1R inhibitor |
AZD3463 |
1356962-20-3 |
| PKR-IN-1 |
PKR-IN-1 |
1260075-17-9 |
| 2-Chloro-6-methyl-N-phenylbenzamide |
2-氯-6-甲基-N-苯基苯甲酰胺 |
1386861-46-6 |
| TAS-116 |
TAS-116 |
1260533-36-5 |
| UM171 |
UM171 |
1448724-09-1 |
| 1-Azabicyclo[2.2.2]octane-4-Methanol, α,α-diphenyl- |
二苯基(奎宁环-4-基)甲醇 |
461648-39-5 |
| VRT-1353385 |
VRT-1353385 |
1616113-45-1 |
QQ
微信
